350 related articles for article (PubMed ID: 20351294)
1. TRPC channels are necessary mediators of pathologic cardiac hypertrophy.
Wu X; Eder P; Chang B; Molkentin JD
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7000-5. PubMed ID: 20351294
[TBL] [Abstract][Full Text] [Related]
2. Isoproterenol-induced hypertrophy of neonatal cardiac myocytes and H9c2 cell is dependent on TRPC3-regulated Ca
Han JW; Kang C; Kim Y; Lee MG; Kim JY
Cell Calcium; 2020 Dec; 92():102305. PubMed ID: 33069962
[TBL] [Abstract][Full Text] [Related]
3. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.
Kuwahara K; Wang Y; McAnally J; Richardson JA; Bassel-Duby R; Hill JA; Olson EN
J Clin Invest; 2006 Dec; 116(12):3114-26. PubMed ID: 17099778
[TBL] [Abstract][Full Text] [Related]
4. PKC-dependent coupling of calcium permeation through transient receptor potential canonical 3 (TRPC3) to calcineurin signaling in HL-1 myocytes.
Poteser M; Schleifer H; Lichtenegger M; Schernthaner M; Stockner T; Kappe CO; Glasnov TN; Romanin C; Groschner K
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10556-61. PubMed ID: 21653882
[TBL] [Abstract][Full Text] [Related]
5. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
[TBL] [Abstract][Full Text] [Related]
6. Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling.
Gao H; Wang F; Wang W; Makarewich CA; Zhang H; Kubo H; Berretta RM; Barr LA; Molkentin JD; Houser SR
J Mol Cell Cardiol; 2012 Nov; 53(5):657-67. PubMed ID: 22921230
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
8. TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation.
Kirschmer N; Bandleon S; von Ehrlich-Treuenstätt V; Hartmann S; Schaaf A; Lamprecht AK; Miranda-Laferte E; Langsenlehner T; Ritter O; Eder P
PLoS One; 2016; 11(12):e0168446. PubMed ID: 27992507
[TBL] [Abstract][Full Text] [Related]
9. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling.
Bush EW; Hood DB; Papst PJ; Chapo JA; Minobe W; Bristow MR; Olson EN; McKinsey TA
J Biol Chem; 2006 Nov; 281(44):33487-96. PubMed ID: 16950785
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart.
Nakayama H; Wilkin BJ; Bodi I; Molkentin JD
FASEB J; 2006 Aug; 20(10):1660-70. PubMed ID: 16873889
[TBL] [Abstract][Full Text] [Related]
11. Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.
Han JW; Lee YH; Yoen SI; Abramowitz J; Birnbaumer L; Lee MG; Kim JY
Mol Cell Biochem; 2016 Oct; 421(1-2):55-65. PubMed ID: 27522668
[TBL] [Abstract][Full Text] [Related]
12. TRPC1 channels are critical for hypertrophic signaling in the heart.
Seth M; Zhang ZS; Mao L; Graham V; Burch J; Stiber J; Tsiokas L; Winn M; Abramowitz J; Rockman HA; Birnbaumer L; Rosenberg P
Circ Res; 2009 Nov; 105(10):1023-30. PubMed ID: 19797170
[TBL] [Abstract][Full Text] [Related]
13. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential channels contribute to pathological structural and functional remodeling after myocardial infarction.
Makarewich CA; Zhang H; Davis J; Correll RN; Trappanese DM; Hoffman NE; Troupes CD; Berretta RM; Kubo H; Madesh M; Chen X; Gao E; Molkentin JD; Houser SR
Circ Res; 2014 Aug; 115(6):567-580. PubMed ID: 25047165
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
Nishida M; Watanabe K; Sato Y; Nakaya M; Kitajima N; Ide T; Inoue R; Kurose H
J Biol Chem; 2010 Apr; 285(17):13244-53. PubMed ID: 20177073
[TBL] [Abstract][Full Text] [Related]
16. TRPC channels as effectors of cardiac hypertrophy.
Eder P; Molkentin JD
Circ Res; 2011 Jan; 108(2):265-72. PubMed ID: 21252153
[TBL] [Abstract][Full Text] [Related]
17. Cdc42 is an antihypertrophic molecular switch in the mouse heart.
Maillet M; Lynch JM; Sanna B; York AJ; Zheng Y; Molkentin JD
J Clin Invest; 2009 Oct; 119(10):3079-88. PubMed ID: 19741299
[TBL] [Abstract][Full Text] [Related]
18. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
[TBL] [Abstract][Full Text] [Related]
19. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels].
Nishida M; Watanabe K; Nakaya M; Kurose H
Yakugaku Zasshi; 2010 Mar; 130(3):295-302. PubMed ID: 20190513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
